Literature DB >> 8674370

Locally advanced rectal cancer: resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy.

F T Huber1, R Stepan, F Zimmermann, U Fink, M Molls, J R Siewert.   

Abstract

PURPOSE: Surgery often fails to achieve local control in advanced rectal cancer. Additional measures are necessary to prevent local recurrence. The aim of this study was to evaluate intraoperative radiation therapy (IORT) (flab technique) combined with preoperative or postoperative radiochemotherapy. PATIENTS/
METHODS: IORT is performed using a flexible flab containing hollow plastic tubes that are connected to a multichannel afterloading device with a 370 Gbq-192-Ir source. Patients receive an intraoperative dose of 15 Gy. Target volumes were measured in a cadaver experiment. From 1989 to 1993, 38 patients were included in this study. Nineteen patients were staged as T3 tumors by preoperative endosonography (Group I) and 19 as T4 tumors (Group II). Patients in Group I underwent resection (abdominoperineal resection (APR), 16; anterior resection, 3) and IORT, followed by postoperative radiochemotherapy (50 Gy/5-fluorouracil), whereas patients in Group II received preoperative radiochemotherapy (40 Gy/5-fluorouracil) followed by resection (APR, 18; anterior resection, 1) and IORT. Mean follow-up was 25.5 months.
RESULTS: Operative radicality in Group I was RO (13), R1 (3), and R2 (3), and in Group II it was RO (14), R1 (3), R2 (2). R2 resections were attributable to preoperative undetected distant metastases. Perioperative mortality was 0 percent in Group I and 10.5 percent (n = 2) in Group II. Postoperative morbidity was 53 percent (n = 10) in Group I and 84 percent (n = 16) in Group II with delayed sacral wound healing being the predominant problem. Stenosis of the ureter occurred in two patients (Group II). Late or persistent therapy-related complications were seen in two patients in Group I and in six patients in Group II. Local recurrence developed in three patients in Group I (15.8 percent) and in two patients in Group II (10.5 percent). Survival data do not reach statistical significance between the two groups because of small numbers but show a favorable trend for the preoperative radiochemotherapy group. When compared with a matched historical control group of patients receiving resection only, adjuvant/neoadjuvant radiotherapy with resection/IORT improves survival significantly.
CONCLUSION: The flab method is a simple but especially practical technique for IORT in the pelvis. Adjuvant/neoadjuvant therapy combined with resection/IORT is associated with high morbidity but acceptable mortality. Preliminary survival data are encouraging and call for a controlled prospective randomized trial.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674370     DOI: 10.1007/bf02054443

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

Review 1.  Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications.

Authors:  Reza Mirnezami; George J Chang; Prajnan Das; Kandiah Chandrakumaran; Paris Tekkis; Ara Darzi; Alexander H Mirnezami
Journal:  Surg Oncol       Date:  2012-12-25       Impact factor: 3.279

2.  Intraoperative radiotherapy for locally advanced rectal cancer.

Authors:  Min Kyu Kang; Myung Se Kim; Jae Hwang Kim
Journal:  J Korean Soc Coloproctol       Date:  2010-08-31

Review 3.  Intraoperative radiotherapy: review of techniques and results.

Authors:  Avinash Pilar; Meetakshi Gupta; Sarbani Ghosh Laskar; Siddhartha Laskar
Journal:  Ecancermedicalscience       Date:  2017-06-29

4.  Efficacy and safety of intraoperative radiotherapy in rectal cancer: A systematic review and meta-analysis.

Authors:  Bin Liu; Long Ge; Jing Wang; Ya-Qiong Chen; Shi-Xun Ma; Pei-Lan Ma; Yun-Qiang Zhang; Ke-Hu Yang; Hui Cai
Journal:  World J Gastrointest Oncol       Date:  2021-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.